882188-87-6

Basic information

• Product Name: 1H-Indazole-1-carboxylic acid, 3-(hydroxyMethyl)-, 1,1-diMethylethyl ester
• Synonyms: 1H-Indazole-1-carboxylic acid, 3-(hydroxyMethyl)-, 1,1-diMethylethyl ester;tert-Butyl 3-(hydroxymethyl)-1H-indazole-1-carboxylate;3-(Hydroxymethyl)-1H-indazole,N1-BOCprotected;3-Hydroxymethyl-indazole-1-carboxylic acid tert-butyl ester
• CAS NO: 882188-87-6
• Molecular Formula: C₁₃H₁₆N₂O₃
• Molecular Weight: 248.27774
• Mol File: 882188-87-6.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1H-Indazole-1-carboxylic acid, 3-(hydroxyMethyl)-, 1,1-diMethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indazole-1-carboxylic acid, 3-(hydroxyMethyl)-, 1,1-diMethylethyl ester(882188-87-6)
• EPA Substance Registry System: 1H-Indazole-1-carboxylic acid, 3-(hydroxyMethyl)-, 1,1-diMethylethyl ester(882188-87-6)

Safety Data

• Hazardous Substances Data: 882188-87-6(Hazardous Substances Data)

Usage

General Description

1H-Indazole-1-carboxylic acid, 3-(hydroxymethyl)-, 1,1-dimethylethyl ester is a chemical compound with the molecular formula C14H18N2O3. It is a derivative of indazole carboxylic acid and is commonly used in the pharmaceutical industry as a building block in the synthesis of various drugs and biologically active molecules. 1H-Indazole-1-carboxylic acid, 3-(hydroxymethyl)-, 1,1-dimethylethyl ester is typically found in the form of a white to off-white solid and is soluble in organic solvents. It is a versatile intermediate that can be used in the production of a wide range of pharmaceuticals and other organic compounds.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 64132-13-4 3-(hydroxymethyl)-1H-indazole 
• 4498-67-3 1H-Indazole-3-carboxylic acid 
• 43120-28-1 methyl 1H-indazole-3-carboxylate 

Downstream Products

• 882188-88-7 tert-butyl 3-formyl-1H-indazole-1-carboxylate 
• 174180-42-8 2-methyl-2-propanyl 3-(bromomethyl)-1H-indazole-1-carboxylate 

Relevant articles and documents

Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities

A series of indazolyl-substituted piperidin-4-yl-aminopyrimidines (IPAPYs) were designed from two potent HIV-1 NNRTIs piperidin-4-yl-aminopyrimidine 3c and diaryl ether 4 as the lead compounds by molecular hybridization strategy. The target molecules 5a-q

EPHA4 CYCLIC PEPTIDE ANTAGONISTS AND METHODS OF USE THEREOF

Disclosed herein are compounds and methods of use thereof for the modulation of EphA4 receptor activity. In an aspect, is provided a method of treating or preventing a disease or disorder mediated by EphA4, comprising administering to a subject in need thereof a therapeutically effective amount of a compound as described herein, including certain embodiments, or the structural Formula (I), (l-A), (II), (III), (IV), (IV-1), (V), (Vl-A), (Vl-B), (VII-1), (VII-2), (VIII-1), or (VIII-2), or an enantiomer, a mixture of enantiomers, a mixture of two or more diastereomers, or an isotopic variant thereof; or a pharmaceutically acceptable salt, solvate, or hydrate thereof.

[6,6] FUSED BICYCLIC HDAC8 INHIBITORS

The present invention is directed to compounds of Formula I: and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or isomers or thereof, wherein R1, R2, R2', L, X, W, Y1,Y2,